Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8FKD

Crystal structure of PPARgamma ligand-binding domain in complex with N-CoR peptide and inverse agonist SR33068

8FKD の概要
エントリーDOI10.2210/pdb8fkd/pdb
分子名称Peroxisome proliferator-activated receptor gamma, Nuclear receptor corepressor 1, 2-chloro-N-(6-cyanopyridin-3-yl)-5-nitrobenzamide, ... (5 entities in total)
機能のキーワードnuclear receptors, tzds, drug design, therapeutic targets, transcription, transcription-agonist complex
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計34504.28
構造登録者
MacTavish, B.S.,Kojetin, D.J. (登録日: 2022-12-21, 公開日: 2024-04-17, 最終更新日: 2025-04-30)
主引用文献MacTavish, B.S.,Zhu, D.,Shang, J.,Shao, Q.,He, Y.,Yang, Z.J.,Kamenecka, T.M.,Kojetin, D.J.
Ligand efficacy shifts a nuclear receptor conformational ensemble between transcriptionally active and repressive states.
Nat Commun, 16:2065-2065, 2025
Cited by
PubMed Abstract: Nuclear receptors (NRs) are thought to dynamically alternate between transcriptionally active and repressive conformations, which are stabilized upon ligand binding. Most NR ligand series exhibit limited bias, primarily consisting of transcriptionally active agonists or neutral antagonists, but not repressive inverse agonists-a limitation that restricts understanding of the functional NR conformational ensemble. Here, we report a NR ligand series for peroxisome proliferator-activated receptor gamma (PPARγ) that spans a pharmacological spectrum from repression (inverse agonism) to activation (agonism) where subtle structural modifications switch compound activity. While crystal structures provide snapshots of the fully repressive state, NMR spectroscopy and conformation-activity relationship analysis reveals that compounds within the series shift the PPARγ conformational ensemble between transcriptionally active and repressive conformations that are natively populated in the apo/ligand-free ensemble. Our findings reveal a molecular framework for minimal chemical modifications that enhance PPARγ inverse agonism and elucidate their influence on the dynamic PPARγ conformational ensemble.
PubMed: 40021712
DOI: 10.1038/s41467-025-57325-4
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.22 Å)
構造検証レポート
Validation report summary of 8fkd
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon